Recurrent Depression - St. Charles MO (Clinical Trial # 11667)
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials. 
| City: |
|
St. Charles |
| State: |
|
MO |
| Zip Code: |
|
63301 |
| Study summary: |
|
A Phase 3, randomized, double-blind, parallel-group, placebo-controlled, fixed-dose study comparing the efficacy and safety of 2 doses (10 and 20 mg) of Lu AA21004 in acute treatment of adults with major depressive disorder. |
| Qualified participants must: |
|
• Be 18 to 75 years of age
•
Be diagnosed with MDD (Major Depressive Disorder)
•
Currently be depressed, with the current episode lasting between 3 months and 2 years
•
Not have any history of drug or alcohol abuse or dependence
•
Be physically healthy |
| Participants may receive: |
|
All study-related evaluations, medication, and doctors' visits at no cost; compensation for those who qualify. |
|
|
|
| Clinic Profile: |
|
View Clinic Profile |
|
Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials or take the Participation Quiz to find out if you are a good candidate for clinical trial participation.